{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:40:36Z","timestamp":1778773236127,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.ygyno.2008.09.025","type":"journal-article","created":{"date-parts":[[2008,10,31]],"date-time":"2008-10-31T08:11:32Z","timestamp":1225440692000},"page":"319-324","source":"Crossref","is-referenced-by-count":43,"title":["Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: High level expression in clear cell carcinoma"],"prefix":"10.1016","volume":"112","author":[{"given":"Brian P.","family":"Adley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara J.","family":"Gleason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Sharon","family":"Stack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.09.025_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA, A Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2008.09.025_bib2","first-page":"4722","article-title":"Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas","volume":"62","author":"Schwartz","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.025_bib3","series-title":"Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament. Atlas of tumor pathology, third series, fascicle 23","author":"Scully","year":"1998"},{"key":"10.1016\/j.ygyno.2008.09.025_bib4","first-page":"185","article-title":"Cytopathology of the ovary","volume":"vol. 107","author":"DeFrias","year":"2002"},{"key":"10.1016\/j.ygyno.2008.09.025_bib5","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1091\/mbc.E03-05-0279","article-title":"Gene expression patterns in ovarian carcinomas","volume":"14","author":"Schaner","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ygyno.2008.09.025_bib6","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1158\/1078-0432.CCR-05-0508","article-title":"Gene expression profiles of serous, endometrioid and clear cell subtypes of ovarian and endometrial cancer","volume":"11","author":"Zorn","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.025_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/gyno.1998.5071","article-title":"Clinical characteristics of clear cell carcinoma of the ovary","volume":"70","author":"Behbakht","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib8","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjc.6603116","article-title":"Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging","volume":"94","author":"Takano","year":"2006","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.09.025_bib9","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","article-title":"Clinical characteristics of clear cell carcinoma of the ovary","volume":"88","author":"Sugiyama","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.09.025_bib10","first-page":"438","article-title":"Clear cell carcinoma of the ovary: poor prognosis compared to serous carcinoma","volume":"19","author":"Tammela","year":"1998","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2006.12.024","article-title":"Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary","volume":"105","author":"Crotzer","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0090-8258(89)90852-4","article-title":"Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma","volume":"32","author":"Jenison","year":"1989","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib13","first-page":"24","article-title":"Membrane type-1 matrix metalloproteinase: substrate diversity in pericellular proteolysis","volume":"vol. 19","author":"Barbolina","year":"2008"},{"key":"10.1016\/j.ygyno.2008.09.025_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.20431","article-title":"MT1-MMP: a potent modifier of pericellular microenvironment","volume":"1","author":"Itoh","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib15","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1074\/jbc.M608428200","article-title":"Microenvironmental regulation of membrane type I matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression","volume":"282","author":"Barbolina","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2008.09.025_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0046-8177(98)90226-X","article-title":"MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts","volume":"29","author":"Afzal","year":"1998","journal-title":"Human Pathol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ajog.2004.02.011","article-title":"Functional role of matrix metalloproteinases in ovarian tumor cell plasticity","volume":"190","author":"Sood","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0303-7207(01)00709-2","article-title":"The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma","volume":"187","author":"Davidson","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1309\/B1YX-L8DB-TGY1-7905","article-title":"Expression of membrane type 1,2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions","volume":"115","author":"Davidson","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib20","first-page":"673","article-title":"Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary","volume":"17","author":"Sakata","year":"2000","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/molehr\/gag074","article-title":"Increased expression of tissue inhibitor of metalloproteinase-2 in clear cell carcinoma of the ovary","volume":"9","author":"Okamoto","year":"2003","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.ygyno.2008.09.025_bib22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.200408028","article-title":"Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP","volume":"167","author":"Sabeh","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib23","doi-asserted-by":"crossref","first-page":"39005","DOI":"10.1074\/jbc.M206874200","article-title":"Collagen binding properties of the membrane type 1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44\u00a0kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage","volume":"277","author":"Tam","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2008.09.025_bib24","doi-asserted-by":"crossref","first-page":"24833","DOI":"10.1074\/jbc.M005631200","article-title":"Functional interplay between type I collagen and cell surface matrix metalloproteinase activity","volume":"276","author":"Ellerbroek","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2008.09.025_bib25","doi-asserted-by":"crossref","first-page":"39042","DOI":"10.1074\/jbc.M404958200","article-title":"Differential regulation of membrane type 1 matrix metalloproteinase activity by ERK1\/2 and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor b1-induced pericellular collagenolysis","volume":"279","author":"Munshi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2008.09.025_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0092-8674(03)00513-0","article-title":"Membrane type 1 matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix","volume":"114","author":"Hotary","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2008.09.025_bib27","first-page":"3194","article-title":"Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells","volume":"61","author":"Fishman","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.025_bib28","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.1074\/jbc.M311870200","article-title":"Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase","volume":"279","author":"Wu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2008.09.025_bib29","first-page":"1635","article-title":"Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrixmetalloproteinase through beta1 integrin","volume":"59","author":"Ellerbroek","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.025_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/path.1711390309","article-title":"Collagen production by human mesothelial cells in vitro","volume":"139","author":"Harvey","year":"1983","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib31","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/ki.1990.150","article-title":"Isolation, culture and characterization of human peritoneal mesothelial cells","volume":"37","author":"Stylianou","year":"1990","journal-title":"Kidney Int."},{"key":"10.1016\/j.ygyno.2008.09.025_bib32","first-page":"5028","article-title":"Progressive ovarian carcinoma induces synthesis of type I and III procollagens in the tumor tissue and peritoneal cavity","volume":"53","author":"Zhu","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.025_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/hupa.2001.21558","article-title":"Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography","volume":"32","author":"Furuya","year":"2001","journal-title":"Human Pathol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0092-8674(00)80064-1","article-title":"MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover","volume":"99","author":"Holmbeck","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2008.09.025_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/sj.bjc.6603863","article-title":"MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells","volume":"97","author":"Sodek","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.09.025_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00004347-199604000-00003","article-title":"72-kd type IV collagenase, type IV collagen, and ki67 antigen in serous tumors of the ovary: a clinicopathologic, immunohistochemical and serological study","volume":"15","author":"Denictolis","year":"1996","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib37","first-page":"2799","article-title":"Tissue and serum metalloproteinase (MMP02) expression in advanced ovarian serous cystoadeno-carcinomas: clinical and prognostic implications","volume":"15","author":"Garzetti","year":"1995","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2008.09.025_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/gyno.1999.5533","article-title":"Gelatinase A immunoreactive protein in ovarian lesions \u2014 prognostic value in epithelial ovarian cancer","volume":"75","author":"Westerlund","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib39","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1158\/1078-0432.CCR-05-2338","article-title":"The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer","volume":"12","author":"Kamat","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.025_bib40","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000110426","article-title":"Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer","volume":"28","author":"Sillanpaa","year":"2007","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ygyno.2008.09.025_bib41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/hed.20365","article-title":"Matrix metalloproteases in head and neck cancer","volume":"28","author":"Rosenthal","year":"2006","journal-title":"Head Neck"},{"key":"10.1016\/j.ygyno.2008.09.025_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(02)00699-7","article-title":"Membrane type 1 matrix metalloproteinase: a key enzyme for tumor invasion","volume":"194","author":"Seiki","year":"2003","journal-title":"Cancer Lett."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808007348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808007348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T19:51:05Z","timestamp":1545681065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808007348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0090825808007348"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.09.025","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}